Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.81M Buy
26,264
+333
+1% +$36.6K 0.05% 306
2026
Q1
$2.73M Sell
25,931
-1,062
-4% -$125K 0.06% 291
2025
Q4
$3.37M Buy
26,993
+19,711
+271% +$2.35M 0.07% 246
2025
Q3
$873K Sell
7,282
-512
-7% -$54.1K 0.03% 407
2025
Q2
$715K Buy
7,794
+4,720
+154% +$431K 0.02% 476
2025
Q1
$270K Buy
3,074
+129
+4% +$12.7K 0.02% 448
2024
Q4
$272K Buy
+2,945
New +$283K 0.02% 504

Other funds holding CRH

Callan Family Office's CRH Position: Q2 2026 in Review

Callan Family Office increased its CRH (CRH) stake by 1.3% in Q2 2026, buying an estimated $36.6K and bringing the position to 26,264 shares worth $2.81M. The position accounts for 0.05% of the portfolio, ranked #306.

Callan Family Office first reported a position in CRH in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.37M in Q4 2025. 1,035 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Callan Family Office held 26,264 shares of CRH worth $2.81M as of Q2 2026.
  • Callan Family Office bought 333 CRH shares in Q2 2026, an estimated $36.6K.
  • CRH made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #306 holding.
  • Callan Family Office first reported a position in CRH in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's CRH position peaked at $3.37M in Q4 2025.
  • 1,035 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.